A recent work using a mouse model has demonstrated the critical need of PI3K pathway activation besides MYC deregulation for the malignant transformation of normal B cells in BL, an aggressive B-cell lymphoma with an extremely high proliferation index [44]. The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.